Risk of Second Primary Bone and Soft-Tissue Sarcomas Among Young Adulthood Cancer Survivors.

Excess sarcoma risks after childhood cancer are well established, but risks among young adulthood cancer survivors are poorly understood. Using US population-based cancer registry data, we compared bone and soft-tissue sarcoma risk vs the general population among 186 351 individuals who were diagnosed with nonsarcoma first primary malignancies at ages 20-39 years from 1975 to 2014 (follow-up through 2015) and survived at least 1 year. Bone sarcomas were rare (n = 50), but risk was statistically significantly elevated overall (2.9-fold) and greater than fivefold after Hodgkin lymphoma, non-Hodgkin lymphoma, and central nervous system tumors. Soft-tissue sarcomas were more common (n = 284) and risks were statistically significantly elevated approximately twofold overall and after melanoma and carcinomas of the breast, thyroid, and testis, and greater than fourfold after Hodgkin lymphoma and central nervous system tumors. Risks varied markedly by subtype, with the highest risks (greater than fourfold) for osteosarcoma and the soft-tissue subtypes of rhabdomyosarcoma and blood vessel and nerve sheath sarcomas. These data demonstrate elevated risk for sarcoma after a range of young adulthood cancers.

[1]  P. Nathan,et al.  Challenges and opportunities in the care of survivors of adolescent and young adult cancers , 2019, Pediatric blood & cancer.

[2]  M. McCabe,et al.  Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): a population-based, cohort study , 2019, The Lancet. Oncology.

[3]  J. Witjes,et al.  Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum Era. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  C. Ronckers,et al.  Risk of Subsequent Bone Cancers Among 69 460 Five-Year Survivors of Childhood and Adolescent Cancer in Europe , 2018, Journal of the National Cancer Institute.

[5]  C. Ronckers,et al.  Risk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe , 2017, Journal of the National Cancer Institute.

[6]  M. Hauptmann,et al.  Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  J. Sandlund,et al.  Non-Hodgkin lymphoma across the pediatric and adolescent and young adult age spectrum. , 2016, Hematology. American Society of Hematology. Education Program.

[8]  P. Rosenberg,et al.  Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li‐Fraumeni syndrome cohort , 2016, Cancer.

[9]  A. Bleyer,et al.  Cancer in Adolescents and Young Adults: A Narrative Review of the Current Status and a View of the Future. , 2016, JAMA pediatrics.

[10]  A. Bleyer,et al.  Increased risk of second malignant neoplasms in adolescents and young adults with cancer , 2016, Cancer.

[11]  J. Raemaekers,et al.  Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma. , 2015, The New England journal of medicine.

[12]  M. Tucker,et al.  Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  S. Fosså,et al.  Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  A. D. de González,et al.  Patterns of Bone Sarcomas as a Second Malignancy in Relation to Radiotherapy in Adulthood and Histologic Type , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[15]  P. Rajaraman,et al.  Risk factors associated with secondary sarcomas in childhood cancer survivors: a report from the childhood cancer survivor study. , 2012, International journal of radiation oncology, biology, physics.

[16]  P. Rajaraman,et al.  Sarcoma risk after radiation exposure , 2012, Clinical Sarcoma Research.

[17]  M. Tucker,et al.  Increased risk of second primary cancers after a diagnosis of melanoma. , 2010, Archives of dermatology.

[18]  J. Coebergh,et al.  Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  H. B. Marsden,et al.  A study of soft tissue sarcomas after childhood cancer in Britain , 2007, British Journal of Cancer.

[20]  L. Strong,et al.  Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. , 2007, Journal of the National Cancer Institute.

[21]  J. Birch,et al.  Classification schemes for tumors diagnosed in adolescents and young adults , 2006, Cancer.

[22]  John D Boice,et al.  Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. , 2005, Journal of the National Cancer Institute.

[23]  B. Asselain,et al.  Radiation‐induced sarcomas after radiotherapy for breast carcinoma , 2005, Cancer.

[24]  Eva Steliarova-Foucher,et al.  International Classification of Childhood Cancer, third edition , 2005, Cancer.

[25]  C. Rubino,et al.  Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment , 2005, Breast Cancer Research and Treatment.

[26]  G. Vassal,et al.  Radiation dose, chemotherapy and risk of soft tissue sarcoma after solid tumours during childhood , 2004, International journal of cancer.

[27]  Yan Liu,et al.  A methodological issue in the analysis of second-primary cancer incidence in long-term survivors of childhood cancers. , 2003, American journal of epidemiology.

[28]  P. Hall,et al.  Second primary malignancies in thyroid cancer patients , 2003, British Journal of Cancer.

[29]  R. Severson,et al.  Sarcoma as a second malignancy after treatment for breast cancer. , 2002, International journal of radiation oncology, biology, physics.

[30]  G. Vassal,et al.  Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood , 1998, International journal of cancer.

[31]  J. Fraumeni,et al.  Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. , 1997, JAMA.

[32]  E. Kramárová,et al.  The international classification of childhood cancer , 1996, International journal of cancer.

[33]  H. B. Marsden,et al.  Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. , 1996, Journal of the National Cancer Institute.

[34]  A. Auquier,et al.  Long-term risk of sarcoma following radiation treatment for breast cancer. , 1991, International journal of radiation oncology, biology, physics.

[35]  P Fraser,et al.  Radiation dose and second cancer risk in patients treated for cancer of the cervix. , 1988, Radiation research.

[36]  D M Green,et al.  Bone sarcomas linked to radiotherapy and chemotherapy in children. , 1987, The New England journal of medicine.